← Back to Search

3D Team Care for Dementia

Led By Richard H Fortinsky, PhD
Research Sponsored by UConn Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Must not have
Bedbound and non-communicative
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights


This trial will test a team care model focused on cognitive vulnerability (the 3Ds) in order to improve outcomes for older adults.

Who is the study for?
This trial is for older adults living at home or in assisted living with dementia, depression, or recent delirium. They should plan to stay local for a year and speak English. It's not for those with schizophrenia/bipolar disorder, bedbound/non-communicative individuals, those expected to live less than a year, or if already in the comparator program.Check my eligibility
What is being tested?
The study tests a Home Based Care Team model led by nurse practitioners against regular telephone check-ins. The goal is to see if this approach reduces hospital visits and improves depression symptoms, disability levels, and overall quality of life.See study design
What are the potential side effects?
Since this trial involves care models rather than medications, traditional side effects are not applicable. However, there may be emotional or psychological impacts from receiving different levels of attention and care.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
I am unable to get out of bed or communicate.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion hospitalized or used emergency department without hospitalization
Secondary outcome measures
Caregiver Assessment of Function and Upset (CAFU)
Family caregiver perceived well-being
GRID Hamilton Rating Scale for Depression (GRID-HAMD), 17-item version.
Other outcome measures
Center for Epidemiologic Studies-Depression Scale (CES-D)
Neuropsychiatric Inventory (NPI-C)
Quality of Life-Alzheimer's Disease Scale (QOL-AD)
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Home Based Care TeamExperimental Treatment1 Intervention
Primarily in-home treatment provided by team led by nurse practitioner with geriatrics and geriatric psychiatry expertise.
Group II: Telephone Based Care TeamActive Control1 Intervention
Primarily telephone-based treatment provided by existing care management program offered by collaborating Medicare Advantage insurer.

Find a Location

Who is running the clinical trial?

UConn HealthLead Sponsor
211 Previous Clinical Trials
60,045 Total Patients Enrolled
3 Trials studying Dementia
791 Patients Enrolled for Dementia
Patient-Centered Outcomes Research InstituteOTHER
563 Previous Clinical Trials
29,991,574 Total Patients Enrolled
6 Trials studying Dementia
51,774 Patients Enrolled for Dementia
University of ConnecticutOTHER
186 Previous Clinical Trials
159,685 Total Patients Enrolled

Media Library

Home Based Care Team Clinical Trial Eligibility Overview. Trial Name: NCT02945085 — N/A
Dementia Research Study Groups: Home Based Care Team, Telephone Based Care Team
Dementia Clinical Trial 2023: Home Based Care Team Highlights & Side Effects. Trial Name: NCT02945085 — N/A
Home Based Care Team 2023 Treatment Timeline for Medical Study. Trial Name: NCT02945085 — N/A
~0 spots leftby Jul 2024